ABVC BioPharma, Inc. Net Income (Loss) Attributable to Parent, Diluted
ABVC BioPharma, Inc. (ABVC) reported Net Income (Loss) Attributable to Parent, Diluted of -$11.81 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2022-11-14
- 2022-09-30: Net Income (Loss) Attributable to Parent, Diluted 9 month -$11.81M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 9 month |
|---|---|
| 2022-09-30 | -$11.81M 10-Q · filed 2022-11-14 |